China Resources Medical Holdings Company Limited (HKG:1515)
Hong Kong · Delayed Price · Currency is HKD 2.740
-0.090 (-3.18%)
At close: Mar 27, 2026
HKG:1515 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9,176 | 9,855 | 10,108 | 7,901 | 4,447 | |
Revenue Growth (YoY) | -6.89% | -2.50% | 27.92% | 77.66% | 61.69% |
Cost of Revenue | 7,735 | 8,045 | 8,202 | 6,595 | 3,514 |
Gross Profit | 1,441 | 1,810 | 1,906 | 1,306 | 933.56 |
Selling, General & Admin | 995.87 | 1,049 | 973.5 | 828.19 | 488.23 |
Other Operating Expenses | 22.28 | -1.1 | 0.18 | -8.06 | - |
Operating Expenses | 1,018 | 1,057 | 1,053 | 856.22 | 565.88 |
Operating Income | 422.62 | 753.21 | 852.46 | 449.6 | 367.68 |
Interest Expense | -49.56 | -61.01 | -114.86 | -55.9 | -16.23 |
Interest & Investment Income | 13.33 | 17.8 | 89.2 | 96.6 | 80.24 |
Earnings From Equity Investments | 78.34 | 98.6 | 90.78 | 88.07 | 83.55 |
Currency Exchange Gain (Loss) | 0.38 | -1.19 | -77.69 | -158.88 | 26.8 |
Other Non Operating Income (Expenses) | 276.97 | 88.83 | 23.74 | 101.05 | -20.32 |
EBT Excluding Unusual Items | 742.07 | 896.24 | 863.63 | 520.53 | 521.72 |
Impairment of Goodwill | - | - | -141.02 | -108.32 | - |
Gain (Loss) on Sale of Investments | 4.12 | -14.23 | -16.52 | 5.63 | -240.1 |
Gain (Loss) on Sale of Assets | 1.51 | -11.19 | -2.39 | 5.41 | - |
Asset Writedown | -0.03 | -32.15 | -210.79 | -0.51 | -11.15 |
Other Unusual Items | - | - | - | 0.2 | - |
Pretax Income | 747.67 | 838.67 | 492.92 | 422.94 | 270.48 |
Income Tax Expense | 191.57 | 166.92 | 165.03 | 94.66 | -155.39 |
Earnings From Continuing Operations | 556.1 | 671.75 | 327.89 | 328.28 | 425.86 |
Minority Interest in Earnings | -60.15 | -105.87 | -70.21 | -62.43 | -7.95 |
Net Income | 495.94 | 565.88 | 257.68 | 265.86 | 417.92 |
Net Income to Common | 495.94 | 565.88 | 257.68 | 265.86 | 417.92 |
Net Income Growth | -12.36% | 119.60% | -3.08% | -36.38% | 34.75% |
Shares Outstanding (Basic) | 1,264 | 1,264 | 1,264 | 1,262 | 1,256 |
Shares Outstanding (Diluted) | 1,264 | 1,264 | 1,264 | 1,262 | 1,264 |
Shares Change (YoY) | - | - | 0.18% | -0.14% | 0.21% |
EPS (Basic) | 0.39 | 0.45 | 0.20 | 0.21 | 0.33 |
EPS (Diluted) | 0.39 | 0.45 | 0.20 | 0.21 | 0.33 |
EPS Growth | -12.86% | 123.79% | -4.76% | -36.36% | 33.64% |
Free Cash Flow | - | 706.57 | 708.44 | 397.31 | 512 |
Free Cash Flow Per Share | - | 0.56 | 0.56 | 0.32 | 0.41 |
Dividend Per Share | 0.134 | 0.132 | 0.060 | 0.033 | 0.098 |
Dividend Growth | 1.52% | 120.00% | 81.82% | -66.33% | 32.43% |
Gross Margin | 15.70% | 18.37% | 18.86% | 16.53% | 20.99% |
Operating Margin | 4.61% | 7.64% | 8.43% | 5.69% | 8.27% |
Profit Margin | 5.41% | 5.74% | 2.55% | 3.36% | 9.40% |
Free Cash Flow Margin | - | 7.17% | 7.01% | 5.03% | 11.51% |
EBITDA | 983.62 | 1,314 | 1,412 | 882.74 | 527.91 |
EBITDA Margin | 10.72% | 13.34% | 13.97% | 11.17% | 11.87% |
D&A For EBITDA | 561 | 561 | 559.11 | 433.14 | 160.23 |
EBIT | 422.62 | 753.21 | 852.46 | 449.6 | 367.68 |
EBIT Margin | 4.61% | 7.64% | 8.43% | 5.69% | 8.27% |
Effective Tax Rate | 25.62% | 19.90% | 33.48% | 22.38% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.